NCT03675997

GRAFted Patients' anxieTY Report

GRAFted Patients' anxieTY Report (GRAFTY)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 30 (actual)
• Sponsor: Institut de Cancérologie de la Loire · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Autograft is a technique requiring several weeks of hospitalization in a protected environment and can be a source of anxiety of different natures for patients. In this study, level of anxiety will be reported weekly throughout hospitalizations for autologous transplant, to detect the most stressful period.

Detailed description

Autograft is one of hematological malignancies treatment, such as lymphoma and myeloma. This technique requires several weeks of hospitalization in a protected environment and can be a source of anxiety of different natures for patients. According to the medical and scientific report of the Biomedicine Agency in 2016, 3 043 patients were involved in an autologous transplant, which represents a significant number of patients potentially exposed to these types of anxiety. That is why it will be interesting in this study to report weekly the level of anxiety throughout their hospitalization for the autologous transplant, to detect the most stressful period. A validated questionnaire will be used: the HAD (Hospital Anxiety and Depression) scale of anxiety and depression.

Conditions

• Autologous Transplant Indication

Interventions

Type	Name	Description
OTHER	HAD (Hospital Anxiety and Depression) scale	HAD (Hospital Anxiety and Depression) scale will be completed and reported by patients the first day of conditioning and then weekly from day 0 corresponding to the autograft, until their last day in the hematological department.

Timeline

• Start date: 2018-11-07
• Primary completion: 2019-09-10
• Completion: 2019-10-20
• First posted: 2018-09-18
• Last updated: 2020-01-29

Locations

1 site across 1 country: France